Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Acurx Pharmaceuticals, Inc. - Common Stock
(NQ:
ACXP
)
2.030
+0.020 (+1.00%)
Streaming Delayed Price
Updated: 3:54 PM EDT, Apr 24, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Acurx Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
November 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
November 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
November 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
November 02, 2023
Via
Benzinga
What's Going On With Acurx Pharmaceuticals Stock?
↗
October 09, 2023
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) shares surged Monday.
Via
Benzinga
Acurx Pharmaceuticals Inc. (NASDAQ: ACXP) Leading the Way in Monday Trading Based on Percentage Gain
October 09, 2023
Via
Investor Brand Network
Preview: Acurx Pharmaceuticals's Earnings
↗
August 11, 2023
Via
Benzinga
Recap: Acurx Pharmaceuticals Q1 Earnings
↗
May 12, 2023
Via
Benzinga
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
November 02, 2023
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders.
Via
Benzinga
A Preview Of Acurx Pharmaceuticals's Earnings
↗
May 11, 2023
Via
Benzinga
Acurx Pharmaceuticals's Earnings: A Preview
↗
March 15, 2023
Via
Benzinga
Acurx Pharmaceuticals Stock Is Plummeting After Biotech Publishes Phase 2 Results
↗
November 02, 2023
Acurx Pharmaceuticals Inc (NASDAQ: ACXP) shares are trading lower after the company
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
November 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
October 27, 2023
Via
Benzinga
Acurx Pharmaceuticals Share Price And Volume Are Surging Ahead Of Phase 2b Trial Data Release ($ACXP)
October 27, 2023
Via
AB Newswire
Topics
Death
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
October 19, 2023
Via
Benzinga
What's Going On With Acurx Pharmaceuticals Inc Stock Today?
↗
October 18, 2023
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) shares are trading higher Wednesday, though the stock remains down more than 30% over the last month.
Via
Benzinga
Top 3 Health Care Stocks That May Implode This Quarter
↗
October 16, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
October 12, 2023
Gainers
Via
Benzinga
What's Going On With Acurx Pharmaceuticals Stock Now?
↗
October 12, 2023
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) shares are blasting higher Thursday and have gained more than 300% over the last five days.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
October 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
October 03, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
October 03, 2023
Pre-market stock movers are a major topic this morning as we check out the biggest ones worth keeping an eye on for Tuesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
↗
October 02, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
July 27, 2023
During Thursday, 56 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
July 17, 2023
On Monday, 50 companies reached new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
July 26, 2023
Wednesday saw 59 companies set new 52-week lows.
Via
Benzinga
Earnings Scheduled For May 12, 2023
↗
May 12, 2023
Companies Reporting Before The Bell • Honda Motor Co (NYSE:HMC) is expected to report earnings for its fourth quarter.
Via
Benzinga
In The Queue: AcurX Pharmaceuticals Earnings…Here’s What Investors Need To Know Before Thursday ($ACXP)
March 15, 2023
Via
AB Newswire
Race To The Cure: Here’s Why Acurx Pharmaceuticals Could Win The Battle To Treat C. difficile ($ACXP)
February 21, 2023
Via
AB Newswire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit